Xencor, Inc. (XNCR)
12.69
+0.76
(+6.37%)
USD |
NASDAQ |
May 01, 16:00
12.68
0.00 (0.00%)
After-Hours: 20:00
Xencor Profit Margin (Quarterly) : -23.56% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -18.92% |
| Rigel Pharmaceuticals, Inc. | -- |
| Ultragenyx Pharmaceutical, Inc. | -62.32% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.42% |
| Return on Assets | -10.28% |
| Return on Invested Capital | -10.83% |
| Gross Profit Margin (Quarterly) | 90.87% |
| Operating Margin (Quarterly) | -189.9% |
| Return on Net Operating Assets | -63.06% |